✦ LIBER ✦

Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor–positive Breast Cancer

✍ Scribed by Sheng Chen MD,Can-Ming Chen MD,Ke-Da Yu MD,Ruo-Ji Zhou MD…

Book ID: 126393693
Publisher: Springer
Year: 2012
Tongue: English
Weight: 447 KB
Volume: 19
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-012-2318-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

440 Prognostic Value of a Positive-to-ne

440 Prognostic Value of a Positive-to-negative Change in Hormonal Receptor Status Following Neoadjuvant Chemotherapy in Patients with Luminal-type Breast Cancer

✍ S. Chen; C.M. Chen; K.D. Yu; R.J. Zhou; Z.M. Shao 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Comparison of classic and quantitative p

Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer

✍ Sirpa Aaltomaa; Pertti Lipponen; Matti Eskelinen; Veli-Matti Kosma; Sinikka Mari 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 541 KB

Prognostic value of positive human epide

Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer

✍ Lorenzo Livi; Icro Meattini; Calogero Saieva; Ciro Franzese; Vanessa Di Cataldo; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Hormonal receptors in locally advanced b

Hormonal receptors in locally advanced breast cancer: Change with response to neoadjuvant chemotherapy?

✍ Don M. Morris; Jackie Edwards; Frank Gelder 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## Abstract Twenty‐one cancers in 20 patients with locally advanced breast cancer were studied. Incisional biopsy was performed without using electrocautery. Tissue was obtained for histology and estrogen (ER) and progesterone (PR) receptors. Patients received chemotherapy after biopsy. All respond

FOXA1 expression after neoadjuvant chemo

FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer

✍ Kawase, Mai; Toyama, Tatsuya; Takahashi, Satoru; Sato, Shinya; Yoshimoto, Nobuya 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 690 KB

417 POSTER Maintenance hormone therapy w

417 POSTER Maintenance hormone therapy with letrozole after first-line chemotherapy in postmenopausal patients with hormone receptor-positive metastatic breast cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB